DC Chemicals · Product datasheet

MC3343 · DC10940

MC3343 is a nonnucleoside DNMT inhibitor for epigenetic reprogramming, osteoblastic differentiation and osteosarcoma research.

ParameterValue
Chemical NameN-[3-[(2-Amino-6-methylpyrimidin-4-yl)amino]phenyl]-3-(quinolin-4-ylamino)benzamide
CAS No.1535187-91-7
SynonymsMC3343; BDBM50448484; N-(3-((2-Amino-6-methylpyrimidin-4-yl)amino)phenyl)-3-(quinolin-4-ylamino)benzamide; N-(3-(2-amino-6-methylpyrimidin-4-ylamino)phenyl)-3-(quinolin-4-ylamino)benzamide; N-[3-[(2-Amino-6-methylpyrimidin-4-yl)amino]phenyl]-3-(quinolin-4-ylamino)benzamide
FormulaC27H23N7O
M.Wt461.5178
SMILESO=C(C1C([H])=C([H])C([H])=C(C=1[H])N([H])C1=C([H])C([H])=NC2=C([H])C([H])=C([H])C([H])=C12)N([H])C1=C([H])C([H])=C([H])C(=C1[H])N([H])C1C([H])=C(C([H])([H])[H])N=C(N([H])[H])N=1
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity summary

MC3343 is a nonnucleoside DNMT inhibitor for epigenetic reprogramming, osteoblastic differentiation and osteosarcoma research.

View referenced In Vitro and In Vivo results on the product page

References

  1. Manara MC, et al. A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy. Molecular cancer therapeutics (2018).

Available packs

  • 10 mg · US$450
  • 25 mg · US$750
  • 50 mg · US$1,100
View product and biological activity →

Cart

Request quotation